文章
- 首頁
- 文章
-
Company Profile
About us
Our goal is to become a "global drug intelligent development platform focusing on rapid release and free adjustable dose". In the initial stage, we will focus on specific valuable drugs, take the drug intelligent adjustable dose platform as the development direction, and aim at different non-patented drugs. -
Company Profile
Organization
-
Company Profile
Core Competence
Areas of Expertise Merdury has integrated a cross-disciplinary technical team, each with 10~20 years of industry-related experience We have mastered -
Company Profile
-
Company Profile
Stackdose technology
可調式智能藥物開發生產技術平台 自動化藥錠開發3D粉末列印 提供新劑型或新成分的藥物開發3D列印平台，縮短藥物開發的製作時間和複雜度 可調式藥物智慧生產系統 幫助醫師及藥師為患者調劑出不同劑量、口味、尺寸，服用藥錠數量最小化，增加患者適口性 自動成型堆疊黏合技術 利用藥錠內多層孔隙結構，層層堆疊成 -
Financial Report
Financial Report
td{width:300px;} Title Downloads 2020 - Consolidated Financial Report for the Fourth Quarter PDF 2021 - Consolidated Financial Report for t -
Monthly Revenues
-
Monthly Revenues
2022 Monthly Revenue
Unit: NT$ thousand td{width:300px;} Month Current Period Last Year YoY Change(%) Jan Feb Mar &nbs -
Monthly Revenues
2023 Monthly Revenue
Unit: NT$ thousand td{width:300px;} Month Current Period Last Year YoY Change(%) Jan - - 999999.99 Feb - - 999999.99 Mar - - 999999.99 Apr - - 999 -
Shareholders' Meeting Information
Shareholders' Meeting Info.
td{width:300px;} Year Time Venue Links 2022 Temporary Shareholders' Meeting 2022/12/05 10:00 15F.,No. 653-1, Bannan Rd., Zhonghe Dist.New Taipei